CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
CP1150 Sound Processor +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05286385
NCT05286385N/ACompleted

A Pre-Marketing, Prospective, Single-Site, Open-Label, Within-Subject, Pilot, Interventional Study of Adult Cochlear Implant Speech Perception With the CP1150 Sound Processor Compared With the Next Generation of Signal Processing Technology

Cochlear·interventional·Posted Mar 18, 2022·Updated Feb 7, 2025

In Brief

A clinical study evaluating CP1150 Sound Processor, CP1150 NF, and 2 other interventions for Hearing Impairment, Sensorineural. Completed, enrolled 10 participants across 1 site.

Detailed Summary

This clinical study aims to investigate speech performance in quiet with an OTE Sound Processor with modified firmware compared with the commercially available CP1150. The study also investigates CP1110 and CP1150 with Forward Focus.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia
CollaboratorsAvania

Timeline

N/ACompletedFinished
2023202420252026
First PostedMar 18, 2022
Enrollment StartMay 30, 2022
Primary CompletionJun 29, 2022
TodayJul 2, 2026
Enrollment to primary: 29 daysPosted 4.3 years ago

Interventions

CP1150 Sound Processordevice

Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor

CP1150 NFdevice

Speech perception tests whilst the subject is fitted with the CP1150 modified firmware (the addition of notch filters at 978Hz, 1956Hz, 2934Hz, 3912Hz).

CP1150 + FFdevice

Speech perception tests whilst the subject is fitted with the CP1150 Sound Processor with ForwardFocus.

CP1110device

Speech perception tests whilst the subject is fitted with the CP1110 Sound Processor.